New Data Shows Delay in Anti-CGRP Medication Response for Some

Real-world data on anti-CGRP monoclonal antibodiesПодробнее

Predictive markers for CGRP-directed antibody treatment success in migraineПодробнее

Response to CGRP Inhibitors: Refractory Migraine & Drug OveruseПодробнее

Preliminary data on the use of anti-CGRP mAbs in pediatric migraineПодробнее

Heads Up Podcast (preview): Exploring New Anti-CGRP Treatments for MigraineПодробнее

CTAF: CGRP Inhibitors for Migraine, Evidence Presentation, June 2018Подробнее

Your CGRP Questions AnsweredПодробнее

The Latest Data on Combining Botox With Anti-CGRP MedicationsПодробнее

Migraine Prevention: New Opportunities for Pain ReliefПодробнее

What are CGRP Inhibitors for Migraine? Calcitonin Gene-Related PeptideПодробнее

Utilizing CGRP-Targeting Monoclonal Antibodies for Migraine PreventionПодробнее

Latest guidelines on anti-CGRP antibodies: first-line and long-term useПодробнее

Lady Gaga’s best response everПодробнее

Migraine Update: CGRPПодробнее

Migraine Prevention: Novel Treatment Strategies for Improved Patient OutcomesПодробнее

Treating migraines in patients not responding to CGRP monoclonal antibodiesПодробнее

Anti CGRP in Migraine Prevention - Headache Update Webinar 11 January 2021Подробнее

News Edition December 2022Подробнее